These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1333137)

  • 21. Low risk of sexual transmission of hepatitis C virus in Somalia.
    Watts DM; Corwin AL; Omar MA; Hyams KC
    Trans R Soc Trop Med Hyg; 1994; 88(1):55-6. PubMed ID: 8154002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An algorithm for confirming screen reactivity in blood donors in enzyme immunoassays for antibodies to hepatitis C virus.
    Craske J; Paver WK; Farmer D
    J Immunol Methods; 1993 Apr; 160(2):227-35. PubMed ID: 7681460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.
    Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ
    J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C antibody and chronic liver disease in haemophilia.
    Makris M; Preston FE; Triger DR; Underwood JC; Choo QL; Kuo G; Houghton M
    Lancet; 1990 May; 335(8698):1117-9. PubMed ID: 1971863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation.
    Tobler LH; Tegtmeier G; Stramer SL; Quan S; Dockter J; Giachetti C; Busch MP
    Transfusion; 2000 Jan; 40(1):15-24. PubMed ID: 10644807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low prevalence of HCV, HIV, and HTLV-I/II infection markers in northwestern Greece: results of a 3-year prospective donor study (1995-1997).
    Zervou EK; Boumba DS; Liaskos C; Georgiadou S; Tsianos EV; Dalekos GN
    Eur J Intern Med; 2003 Feb; 14(1):39-44. PubMed ID: 12554009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
    Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
    Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
    Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
    Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic events during the incubation period of hepatitis C virus infection: the role of antibodies to E2 glycoprotein. Multicentre Hemodialysis Cohort Study on Viral Hepatitis.
    Psichogiou M; Katsoulidou A; Vaindirli E; Francis B; Lee SR; Hatzakis A
    Transfusion; 1997 Aug; 37(8):858-62. PubMed ID: 9280333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Third-generation hepatitis C virus tests in asymptomatic anti-HCV-positive blood donors.
    Craxì A; Valenza M; Fabiano C; Magrin S; Fiorentino G; Diquattro O; Pagliaro L
    J Hepatol; 1994 Nov; 21(5):730-4. PubMed ID: 7890886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of third-generation screening and confirmatory assays for HCV antibodies.
    Uyttendaele S; Claeys H; Mertens W; Verhaert H; Vermylen C
    Vox Sang; 1994; 66(2):122-9. PubMed ID: 7514324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of a recombinant immunoblot assay in the interpretation of anti-hepatitis C virus reactivity among prospectively followed patients, implicated donors, and random donors.
    Alter HJ; Tegtmeier GE; Jett BW; Quan S; Shih JW; Bayer WL; Polito A
    Transfusion; 1991 Oct; 31(8):771-6. PubMed ID: 1656553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.
    Mathiesen UL; Ekermo B; Foberg U; Franzén L; Frydén A; Norlin R; Pettersson LG; Sterling H; Widell A; Bodemar G
    Scand J Gastroenterol; 1992 Jun; 27(6):443-8. PubMed ID: 1321487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody response to hepatitis C virus infection after liver transplantation.
    Hsu HH; Wright TL; Tsao SC; Combs C; Donets M; Feinstone SM; Greenberg HB
    Am J Gastroenterol; 1994 Aug; 89(8):1169-74. PubMed ID: 7519818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved detection of antibodies to hepatitis C virus in dialysis patients using a second-generation enzyme immunoassay.
    de Medina M; Ortiz C; Krenc C; Leete J; Vallari D; Hill M; LaRue S; Jimenez M; Anderson W; Schiff E
    Am J Kidney Dis; 1992 Dec; 20(6):589-91. PubMed ID: 1334368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The accuracy of SM-HCV rapid test for the detection of antibody to hepatitis C virus.
    Yuen MF; Hui CK; Yuen JC; Young JL; Lai CL
    Am J Gastroenterol; 2001 Mar; 96(3):838-41. PubMed ID: 11280561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis C in hemophiliac patients in Maracaibo, Venezuela].
    Arteaga-Vizcaíno M; Blitz-Dorfman L; Echeverría JM; León P; Weir-Medina J; Diez-Ewald M; Vizcaíno G; Torres E; Porto-Espinoza L
    Invest Clin; 1993; 34(3):113-8. PubMed ID: 7512388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users.
    Filice G; Patruno S; Campisi D; Chiesa A; Orsolini P; Debiaggi M; Bruno R; Tinelli M
    New Microbiol; 1993 Jan; 16(1):35-42. PubMed ID: 7682283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors.
    Tobler LH; Busch MP; Wilber J; Dinello R; Quan S; Polito A; Kochesky R; Bahl C; Nelles M; Lee SR
    Transfusion; 1994 Feb; 34(2):130-4. PubMed ID: 8310482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.